Topics

Novel Conjugate Shows Promise in HER2-Expressing Cancers

20:00 EDT 8 Jul 2019 | Cancer Networks

Researchers tested the novel antibody-drug conjugate trastuzumab duocarmazine in patients with heavily pretreated HER2-expressing metastatic cancers, including breast cancer.

Original Article: Novel Conjugate Shows Promise in HER2-Expressing Cancers

NEXT ARTICLE

More From BioPortfolio on "Novel Conjugate Shows Promise in HER2-Expressing Cancers"

Quick Search

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...